A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy
From MaRDI portal
Publication:3616427
DOI10.1093/imammb/dqn024zbMath1157.92024WikidataQ51862275 ScholiaQ51862275MaRDI QIDQ3616427
Alberto d'Onofrio, Alberto Gandolfi
Publication date: 25 March 2009
Published in: Mathematical Medicine and Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/imammb/dqn024
92C50: Medical applications (general)
34K20: Stability theory of functional-differential equations
34K60: Qualitative investigation and simulation of models involving functional-differential equations
34K18: Bifurcation theory of functional-differential equations
Related Items
Delay Differential Equations in Bio-Populations, WKB theory of large deviations in stochastic populations, Traveling waves and free boundaries arising in tumor angiogenesis, Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy, Local controllability and optimal control for a model of combined anticancer therapy with control delays, The nature of Hopf bifurcation for the Gompertz model with delays, Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments, Time delay in physiological systems: analyzing and modeling its impact, Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method, A generalization of Gompertz law compatible with the Gyllenberg-Webb theory for tumour growth, Analysis of the Hopf bifurcation for the family of angiogenesis models, Analysis of the Hopf bifurcation for the family of angiogenesis models. II: The case of two nonzero unequal delays, On optimal delivery of combination therapy for tumors, Understanding the antiangiogenic effect of metronomic chemotherapy through a simple mathematical model, Modeling tumor growth inhibition and toxicity outcome after administration of anticancer agents in xenograft mice: a dynamic energy budget (DEB) approach, Sensitivity of combined chemo- and antiangiogenic therapy results in different models describing cancer growth, Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruning, Nonlinear dynamics in tumor-immune system interaction models with delays, Stability analysis of the family of tumour angiogenesis models with distributed time delays, Optimisation of Cancer Drug Treatments Using Cell Population Dynamics, Tumor Development Under Combination Treatments with Anti-angiogenic Therapies, Mathematical model of cancer growth controled by metronomic chemotherapies
